Precision Biosciences (DTIL) Cash from Operations Growth (3y) (2021 - 2026)
Precision Biosciences (DTIL) Cash from Operations Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | -5.07% |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - | - |
| 4 | BeOne Medicines | 471.47 Bn | 466.67 Bn | 1.35 Bn | 33.08% |
| 5 | Vertex Pharmaceuticals | 121.76 Bn | 114.52 Bn | 2.59 Bn | 16.64% |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.15 Bn | 3.31 Bn | -7.60% |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - | - |
| 8 | Argenx Se | 55.77 Bn | 50.59 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.45 Bn | 37.45 Bn | - | - |
| 10 | Precision Biosciences | 179.83 Mn | 151.54 Mn | - | 27.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.61% |
| Dec 31, 2025 | 19.84% |
| Sep 30, 2025 | -36.14% |
| Jun 30, 2025 | 5.77% |
| Mar 31, 2025 | 12.94% |
| Dec 31, 2024 | 7.60% |
| Sep 30, 2024 | 37.23% |
| Jun 30, 2024 | 22.01% |
| Mar 31, 2024 | -31.59% |
| Dec 31, 2023 | 14.45% |
| Sep 30, 2023 | -1.29% |
| Jun 30, 2023 | 6.43% |
| Mar 31, 2023 | -6.69% |
| Dec 31, 2022 | -2.04% |
| Sep 30, 2022 | 59.90% |
| Jun 30, 2022 | -13.48% |
| Mar 31, 2022 | -13.19% |
| Dec 31, 2021 | -22.41% |
| Sep 30, 2021 | -16.68% |
| Jun 30, 2021 | -49.87% |